论文部分内容阅读
Cancer Therapeutics exploits the subtle differences one can find between cancer and normal cells to fight off cancer.These differences can be present on their cell surfaces,and such biomarkers can be utilized as the tumor-associated antigens (TAAs) to which one can conceivably deliver cytotoxic compounds to kill the TAA-bearing cells.